- Release Date: 13/03/23 09:10
- Summary: FDA approves Daybue - the first treatment for Rett syndrome
- Price Sensitive: Yes
- Download Document 258.83KB
- Forums
- ASX - By Stock
- Ann: FDA approves Daybue - the first treatment for Rett syndrome
Ann: FDA approves Daybue - the first treatment for Rett syndrome
-
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$19.70 |
Change
-0.270(1.35%) |
Mkt cap ! $2.523B |
Open | High | Low | Value | Volume |
$19.96 | $19.96 | $19.69 | $2.534M | 128.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 69 | $19.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.71 | 668 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 516 | 19.720 |
6 | 737 | 19.710 |
3 | 2681 | 19.700 |
5 | 272 | 19.690 |
5 | 678 | 19.680 |
Price($) | Vol. | No. |
---|---|---|
19.730 | 650 | 8 |
19.740 | 562 | 9 |
19.750 | 439 | 7 |
19.760 | 216 | 4 |
19.770 | 201 | 4 |
Last trade - 14.26pm 05/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |